ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N03AX18 | B | Lacosamide - 50mg | 7469 | 185984/13 | VIMPAT | 50mg | 14 | Tablet, film coated | Oral | Sadco | Aesica Pharmaceuticals GmbH | Germany | 1,024,008 L.L | 23.08 | A2 | UCB Pharma SA | Belgium | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N03AX18 | G | Lacosamide - 50mg | 10847 | 156019/1 | LACOSAMIDE/GENEPHARM | 50mg | 14 | Tablet | Oral | Nobel Pharm Plus SARL | Genepharm SA | Greece | 614,136 L.L | 23.08 | A1 | Genepharm SA | Greece | 2/5/2024 | 0 |